Example: Heart Attack

Search clinical trials for: Combretastatin

Total 19 results

NCT01423149

Completed

Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia

Conditions: Choroidal Neovascularization; Myopia, Degenerative
NCT00113438

Completed

Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors

Conditions: Cancer; Tumor
NCT00960557

Completed

Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden

Conditions: Neoplasm Metastasis
NCT00060242

Completed

Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer

Conditions: Head and Neck Cancer
NCT01570790

Completed

Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration

Conditions: Combretastatin A4 Phosphate; Age-related Macular Degeneration; AMD; CNV; Choroidal Neovascularization
NCT00395434

Completed

Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors

Conditions: Tumors
NCT00077103

Terminated

Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer

Conditions: Head and Neck Cancer
NCT00507429

Terminated

Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer
NCT01085656

Terminated

A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS

Conditions: Leukemia, Myelogenous, Acute; Myelodysplastic Syndromes
NCT02279602

Completed

Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study

Conditions: Neuroendocrine Tumors
NCT02132468

Completed

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers

Conditions: Neuroendocrine Tumors
NCT01023295

Completed

Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)

Conditions: Polypoidal Choroidal Vasculopathy
NCT02641639

Terminated

FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer

Conditions: Platinum Resistant Ovarian Cancer
NCT00653939

Completed

A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer

Conditions: Tumors
NCT02576301

Unknown status

Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS

Conditions: Acute Myelogenous Leukemia; Myelodysplastic Syndromes
NCT00003768

Completed

Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
NCT00003698

Completed

Chemotherapy in Treating Patients With Solid Tumors

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
NCT01701349

Withdrawn

Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer
NCT00699517

Completed

A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies

Conditions: Sarcoma